Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marubeni America Corporation is the largest overseas subsidiary of Marubeni Corporation, a major Japanese general trading house (sogo shosha). Within the life sciences and healthcare sectors, the company operates as a strategic investor, distributor, and business developer, focusing on pharmaceuticals, medical devices, and healthcare services. Marubeni America facilitates market entry for international companies into Japan and other Asian markets while investing in innovative biotech and digital health platforms. Their activities include managing supply chains for raw materials, partnering with biotech firms for drug development, and expanding healthcare infrastructure globally. The company leverages its global network to provide comprehensive logistics, financing, and marketing support for healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marubeni America.